- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Aggressive B-cell Lymphomas
Total 3859 results
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities LimitedActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
OriCell Therapeutics Co., Ltd.Enrolling by invitationRelapsed and/or Refractory Multiple MyelomaChina
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
HitGen Inc.TerminatedMultiple Myeloma | Relapsed and Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.TerminatedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
Thomas Martin, MDWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Merck Sharp & Dohme LLCCompleted
-
PETHEMA FoundationCompletedRelapsed and Refractory Multiple MyelomaSpain
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Xinhua Hospital, Shanghai Jiao Tong University...CARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
Kosin University Gospel HospitalCompletedRelapsed and/or refractorY Multiple MyelomaKorea, Republic of
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.UnknownRefractory or Relapsed Multiple MyelomaChina
-
The Pregene (ShenZhen) Biotechnology Company, Ltd.Henan Cancer HospitalUnknownRelapsed and Refractory Multiple MyelomaChina
-
Allife Medical Science and Technology Co., Ltd.UnknownRelapsed and Refractory Multiple Myeloma
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbAbbVieCompletedRelapsed and/or Refractory Multiple MyelomaSpain
-
Piramal Enterprises LimitedCompletedRelapsed and/or Refractory Multiple MyelomaIndia
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingHematopoietic and Lymphoid Cell Neoplasm | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
Genesis Pharma S.A.CompletedRelapse/Refractory Multiple MyelomaGreece
-
University of WuerzburgCompletedRefractory Multiple Myeloma | RelapseGermany
-
Xencor, Inc.ICON Clinical ResearchCompletedAcute Myelogenous Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm | B-cell Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia, Blast CrisisUnited States
-
University of Alabama at BirminghamBoehringer IngelheimCompletedRenal Cell Carcinoma | Non-squamous Non-small Cell Lung Cancer | Cervical Carcinoma | Colorectal Adenocarcinoma | Platinum-refractory Ovarian CarcinomaUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPhiladelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD19 PositiveUnited States
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.RecruitingPhiladelphia Chromosome Positive | Adult B Acute Lymphoblastic LeukemiaUnited States
-
He HuangYake Biotechnology Ltd.RecruitingRelapse/Refractory Multiple MyelomaChina
-
Antengene CorporationCompletedRelapse/Refractory Multiple MyelomaChina
-
Sun Yat-sen UniversityWithdrawnRelapse/Refractory Multiple MyelomaChina